Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma.
Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma.
复制标题
DOI:
10.1016/j.cyto.2011.12.017
复制
发表时间:
2012-04
期刊:
影响因子:
3.8
通讯作者:
Atamas, Sergei P.
中科院分区:
文献类型:
--
作者:
Luzina, Irina G.;Lockatell, Virginia;Lavania, Sachin;Pickering, Edward M.;Kang, Phillip H.;Bashkatova, Yulia N.;Andreev, Sergey M.;Atamas, Sergei P.
We have previously described an alternatively spliced isoform of IL-4 mRNA that omits exon 2 and is termed IL-4δ2. However, the natural production of IL-4δ2 protein and its association with disease have not been previously assessed due to unavailability of an antibody that interacts with IL-4δ2 without cross-reactivity with full length IL-4. We used a unique monoclonal antibody (mAb) that reacts with IL-4δ2, but not with IL-4, and observed that IL-4δ2 is naturally produced by T cells from patients with asthma, but not from healthy controls. The kinetics of IL-4δ2 and IL-4 production by phorbol myristate acetate (PMA)/ionomycin-activated cells differed, with IL-4δ2 increasing at 48 – 72 h and IL-4 peaking at 24 h. The steady-state levels of IL-4δ2 mRNA varied significantly among the donors and were discordant with the corresponding protein levels, suggesting post-transcriptional regulation of protein production. Polarized Th1 or Th2 lymphocytes were not a major source of IL-4δ2. Stimulation of cultured T lymphocytes with IL- 4δ2 caused elevated production of IFN-γ, IL-10, IL-6, MCP-1, and TNF-α, with notable differences between patients and controls in the production of IFN-γ, IL-10, and IL-6. Thus, IL- 4δ2 is natively produced not only as mRNA but also as a protein by cells other than Th1 or Th2. It is regulated post-transcriptionally, is associated with allergic asthma, and regulates production of other cytokines by primary T lymphocytes. Alternatively spliced interleukin-4 may be a new biomarker, a pathophysiological player, and possibly a molecular target for future therapies in asthma.
登录
查看更多内容
DOI:
10.1177/039463200702000417
发表时间:
2007-10-01
影响因子:
3.5
作者:
Orsini, B.;Vivas, J. R.;D'Elios, M. M.
通讯作者:
D'Elios, M. M.
影响因子:
6.4
作者:
Fletcher, HA;Owiafe, P;Brookes, RH
通讯作者:
Brookes, RH
影响因子:
14.2
作者:
Glare, EM;Divjak, W;Walters, EH
通讯作者:
Walters, EH
影响因子:
6.4
作者:
Luzina, Irina G.;Lockatell, Virginia;Atamas, Sergei P.
通讯作者:
Atamas, Sergei P.
影响因子:
1.8
作者:
Waldvogel, AS;Lepage, MF;Heussler, VT
通讯作者:
Heussler, VT